Aim To modify the structure of resibufogenin by using Ginkgo bilobasuspension. Methods Young leaves of Ginkgo biloba were differentiated into callus in MS medium withonly 2,4-D as plant growth regulator. The callus wa...Aim To modify the structure of resibufogenin by using Ginkgo bilobasuspension. Methods Young leaves of Ginkgo biloba were differentiated into callus in MS medium withonly 2,4-D as plant growth regulator. The callus was then transferred aseptically to liquid MSmedium exoge-nously supplemented with appropriate concentration of 6-BA, NAA and 2,4-D to establishsuspension cell culture system. Resibufogenin was administered into the well-grown cell cultures andincubated for 4 d. The products dissolved in the liquid phase of the cultures were extracted andpurified by silica gel column chromatography gradiently eluted with petroleum ether and acetonesystem. Results One transformed product was obtained in 40% yield after 4 d incubation, which wasidentified as 3-epi-resibufogenin on the basis of FAB MS, ~1H NMR and ^(13)C NMR spectroscopicanalysis and corresponding data reported in literature. Conclusion G. biloba suspension cultures canbe used as an enzyme system to biotransform resibufogenin, an animal-originated bufadienolide, into3-epi-resibufogenin.展开更多
目的:从开菲尔粒和陈年泡菜水中分离出具有降胆固醇能力的乳酸杆菌,探讨其降解小鼠血清胆固醇的机理。方法:以耐酸性、胆盐耐受性、疏水性、胆盐水解酶活性以及降胆固醇特性筛选出1株性状优良的植物乳杆菌(Lactobacillus plantarum DMDL...目的:从开菲尔粒和陈年泡菜水中分离出具有降胆固醇能力的乳酸杆菌,探讨其降解小鼠血清胆固醇的机理。方法:以耐酸性、胆盐耐受性、疏水性、胆盐水解酶活性以及降胆固醇特性筛选出1株性状优良的植物乳杆菌(Lactobacillus plantarum DMDL 9010)。将50只8周龄的Sprague Dawley大鼠随机分为正常组、模型组、阳性组、9010高组、9010低组,分别饲喂28 d和70 d采血,测定总胆固醇(total cholesterol,TC)、甘油三酯(triglyceride,TG)、高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)、低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)的含量,70 d取肝组织细胞实时荧光逆转录聚合酶链式反应检测胆固醇合成限速酶3-羟基-3-甲基戊二酸单酰辅酶A还原酶(3-hydroxy-3-methylglutaryl-Co A reducase,HMGCR)的相对表达量。结果:筛选得到1株具有降胆固醇能力的L.plantarum DMDL 9010,胆固醇去除率为37.58%,胆盐耐受性为35.48%,疏水性高达40%,具有较好的耐酸性。饲喂第28天,成功建出高脂模型大鼠,饲喂第70天,9010高组能显著降低高脂大鼠血清TC(23.03%)和LDL-C(28.00%),9010低组和阳性组无明显差异。阳性组和9010高组分别下调肝脏中HMG-Co A基因m RNA的表达(79.92%和62.86%)(P<0.05)。结论:实验获得了1株在体内外均具有高效降胆固醇能力的L.plantarum DMDL 9010,可进一步开发为功能性微生态制剂。展开更多
文摘Aim To modify the structure of resibufogenin by using Ginkgo bilobasuspension. Methods Young leaves of Ginkgo biloba were differentiated into callus in MS medium withonly 2,4-D as plant growth regulator. The callus was then transferred aseptically to liquid MSmedium exoge-nously supplemented with appropriate concentration of 6-BA, NAA and 2,4-D to establishsuspension cell culture system. Resibufogenin was administered into the well-grown cell cultures andincubated for 4 d. The products dissolved in the liquid phase of the cultures were extracted andpurified by silica gel column chromatography gradiently eluted with petroleum ether and acetonesystem. Results One transformed product was obtained in 40% yield after 4 d incubation, which wasidentified as 3-epi-resibufogenin on the basis of FAB MS, ~1H NMR and ^(13)C NMR spectroscopicanalysis and corresponding data reported in literature. Conclusion G. biloba suspension cultures canbe used as an enzyme system to biotransform resibufogenin, an animal-originated bufadienolide, into3-epi-resibufogenin.
